ReShape Lifesciences Inc. (RSLS)

ReShape Lifesciences Stock Forecast

Stock Price Forecast

There have not been any analyst price target forecasts for ReShape Lifesciences in the last 12 months.

Price Target: n/a

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for ReShape Lifesciences.

Recommendation Trends

Rating	Apr '24	May '24	Jun '24	Jul '24
Strong Buy	2	2	2	0
Buy	0	0	0	0
Hold	0	0	0	0
Sell	0	0	0	0
Strong Sell	0	0	0	0
Total	2	2	2	0

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Anthony Vendetti Maxim Group	Maxim Group	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Jul 17, 2024
Ben Haynor Alliance Global Partners	Alliance Global Partners	Strong Buy Maintains $398,750 → $337,125	Strong Buy	Maintains	$398,750 → $337,125	+2,149,931.89%	May 26, 2022
Anthony Vendetti Maxim Group	Maxim Group	Strong Buy Initiates $580,000	Strong Buy	Initiates	$580,000	+3,698,879.59%	Oct 8, 2021

More Analyst Ratings

Financial Forecast

Revenue This Year

12.23M

Increased by 52.80%

from 8.01M

Revenue Next Year

n/a

from 12.23M

EPS This Year

-0.37

from -345.73

EPS Next Year

n/a

from -0.37

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025
Revenue	11.30M	13.60M	11.24M	8.68M	8.01M	12.23M
Revenue Growth	-25.12%	20.37%	-17.35%	-22.79%	-7.74%	52.80%
EPS	-	-	-	-	-345.73	-0.37
EPS Growth	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025
High	12.6M
Avg	12.2M
Low	11.8M

Revenue Growth

Revenue Growth	2025
High	57.3%
Avg	52.8%
Low	46.8%

EPS Forecast

EPS	2025
High	-0.38
Avg	-0.37
Low	-0.35

EPS Growth

EPS Growth	2025
High	-
Avg	-
Low	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.